GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TYK Medicines Inc (HKSE:02410) » Definitions » Enterprise Value

TYK Medicines (HKSE:02410) Enterprise Value : HK$9,743.18 Mil (As of Apr. 12, 2025)


View and export this data going back to 2024. Start your Free Trial

What is TYK Medicines Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, TYK Medicines's Enterprise Value is HK$9,743.18 Mil. TYK Medicines's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-231.52 Mil. Therefore, TYK Medicines's EV-to-EBIT ratio for today is -42.08.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, TYK Medicines's Enterprise Value is HK$9,743.18 Mil. TYK Medicines's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-215.59 Mil. Therefore, TYK Medicines's EV-to-EBITDA ratio for today is -45.19.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, TYK Medicines's Enterprise Value is HK$9,743.18 Mil. TYK Medicines's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.00 Mil. Therefore, TYK Medicines's EV-to-Revenue ratio for today is .

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, TYK Medicines's Enterprise Value is HK$9,743.18 Mil. TYK Medicines's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-167.37 Mil. Therefore, TYK Medicines's EV-to-FCF ratio for today is -58.21.


TYK Medicines Enterprise Value Historical Data

The historical data trend for TYK Medicines's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TYK Medicines Enterprise Value Chart

TYK Medicines Annual Data
Trend Dec22 Dec23 Dec24
Enterprise Value
- - 17,954.18

TYK Medicines Quarterly Data
Dec22 Mar23 Jun23 Dec23 Mar24 Jun24 Dec24
Enterprise Value Get a 7-Day Free Trial - - - - 17,954.18

Competitive Comparison of TYK Medicines's Enterprise Value

For the Biotechnology subindustry, TYK Medicines's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TYK Medicines's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TYK Medicines's Enterprise Value distribution charts can be found below:

* The bar in red indicates where TYK Medicines's Enterprise Value falls into.


;
;

TYK Medicines Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

TYK Medicines's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

TYK Medicines's Enterprise Value for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TYK Medicines  (HKSE:02410) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

TYK Medicines's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=9743.179/-231.519
=-42.08

TYK Medicines's current Enterprise Value is HK$9,743.18 Mil.
TYK Medicines's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-231.52 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

TYK Medicines's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=9743.179/-215.593
=-45.19

TYK Medicines's current Enterprise Value is HK$9,743.18 Mil.
TYK Medicines's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-215.59 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

TYK Medicines's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=9743.179/0
=

TYK Medicines's current Enterprise Value is HK$9,743.18 Mil.
TYK Medicines's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

TYK Medicines's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=9743.179/-167.373
=-58.21

TYK Medicines's current Enterprise Value is HK$9,743.18 Mil.
TYK Medicines's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-167.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TYK Medicines Enterprise Value Related Terms

Thank you for viewing the detailed overview of TYK Medicines's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


TYK Medicines Business Description

Traded in Other Exchanges
N/A
Address
No. 1278 Mingzhu Road, Room 1403-2, Floor 14, Tower A, Changxing World Trade Building, Zhejiang Province, Changxing Economic Development Zone, Huzhou, CHN
TYK Medicines Inc is a drug discovery research and development centre. The company and its subsidiaries are principally engaged in the research, development and commercialization of pharmaceutical products.
Executives
Nan Jing Yi Da Tou Zi Guan Li You Xian Gong Si
Nan Jing Yi Da Zi Ben Guan Li Qi Ye You Xian He Huo
Jiang Su Yi Da Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Wu Yusheng 2201 Interest of corporation controlled by you
Zhu Julia Ming 2202 Interest of your spouse
Zheng Zhou Tai Ji Hong Nuo Yi Yao Gu Fen You Xian Gong Si 2101 Beneficial owner
Zhang Xing Li Yuan Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
He Chao 2201 Interest of corporation controlled by you
Bei Jing Hou Ji Jing Qiao Chuang Ye Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Bei Jing Rong Chen Hou Ji Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Zhang Xing Xing Zhang Chan Ye Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner

TYK Medicines Headlines

No Headlines